E
Applied DNA Sciences, Inc. APDN
$0.1296 $0.00131.01%
Recommendation
Sell
Prev Close
$0.1283
Volume
738,695
Avg Vol (90D)
4,735,983
Market Cap
$7.08M
Dividend & Yield
--
52-Week Range
$0.1204 - $11.76
P/E (TTM)
--
EPS (TTM)
-$5.72
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D-
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Applied DNA Sciences, Inc. (NASDAQ:APDN) Q1 2025 Earnings Call Transcript
2/15/2025 - Insider Monkey
Applied DNA Sciences Inc. Earnings Call Highlights Mixed Sentiment
2/15/2025 - TipRanks Financial Blog
Applied DNA Sciences, Inc. (APDN) Q1 2025 Earnings Call Transcript
2/14/2025 - Seeking Alpha: Transcripts
Applied DNA Sciences, Inc. (APDN) Q1 2025 Earnings Call Transcript
2/14/2025 - SeekingAlpha
Applied DNA Sciences Inc (APDN) Q1 2025 Earnings Call Highlights: Strategic Restructuring and ...
2/14/2025 - GuruFocus
Q1 2025 Applied DNA Sciences Inc Earnings Call Transcript
2/14/2025 - GuruFocus
Applied DNA Sciences (APDN) Reports Q1 Loss, Tops Revenue Estimates
2/13/2025 - Zacks Investment Research
Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress
2/13/2025 - Accesswire
Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025
2/12/2025 - Accesswire
Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14
2/11/2025 - Accesswire
Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates
1/10/2025 - Accesswire
Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter
1/8/2025 - Accesswire
SABBY MANAGEMENT, LLC Acquires Significant Stake in Applied DNA Sciences Inc
1/4/2025 - GuruFocus
Applied DNA Customer UHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA
12/18/2024 - Accesswire
Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates
12/17/2024 - Zacks Investment Research
Applied DNA Sciences GAAP EPS of -$0.32 beats by $0.02, revenue of $0.81M misses by $0.09M
12/17/2024 - SeekingAlpha.com: All News
Applied DNA Sciences Announces Leadership Changes and Restructuring
12/17/2024 - TipRanks Financial Blog
Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines
12/17/2024 - Accesswire
Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out
12/16/2024 - Accesswire
Applied DNA Sciences files to sell 41.64M shares of common stock for holders
11/19/2024 - The Fly
Anson Funds Management LP Acquires New Stake in Applied DNA Sciences Inc
11/15/2024 - GuruFocus
Intellicheck Mobilisa, Inc. (IDN) Reports Q3 Loss, Misses Revenue Estimates
11/13/2024 - Zacks Investment Research
GrafTech International (EAF) Reports Q3 Loss, Tops Revenue Estimates
11/12/2024 - Zacks Investment Research
Resideo Technologies (REZI) Q3 Earnings and Revenues Top Estimates
11/7/2024 - Zacks Investment Research
Applied DNA Sciences prices 20.3M shares at 32c in registered direct offering
10/30/2024 - The Fly
Income Statement
Total Revenue (TTM)
$3.74M
EBITDA (TTM)
-$12.74M
EBIT (TTM)
-$13.20M
Net Income (TTM)
-$8.53M
Balance Sheet
Total Assets (Q)
$15.97M
Total Debt (Q)
$607.30K
Total Liabilities (Q)
$3.42M
Book Value Per Share (Q)
$0.2357
Cash Flow
Cash from Operations (TTM)
-$13.28M
Cash from Investing (TTM)
-$524.80K
Cash from Financing (TTM)
$19.74M
Net Change in Cash (TTM)
$5.94M
Filings
Filing Date
Thursday, February 13, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
3.82
7-Day Total Return
-10.56%
30-Day Total Return
-26.78%
60-Day Total Return
-19.35%
90-Day Total Return
-62.77%
Year to Date Total Return
-47.53%
1-Year Total Return
-98.85%
2-Year Total Return
-99.49%
3-Year Total Return
-99.70%
5-Year Total Return
-99.86%
52-week Low
Dec 13, 2024 - $0.1204
52-week High
Mar 12, 2024 - $11.76
Valuation
Market Cap
$7.08M - Nano Cap
Enterprise Value
-$1.81M
Price/Sales (TTM)
1.08
Price/Book (Q)
0.54
Dividends and Shares
Shares Outstanding
31.52M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.adnas.com
Phone Number
631 240 8800
Address
50 Health Sciences Drive
Stony Brook, NY 11790
Country
United States
Year Founded
1983
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally... more
NASDAQ 03/06/2025 4:00PM Eastern Quotes delayed
Weiss Ratings